Improving Cancer Immunotherapy Systemic Delivery

Purdue University researchers are creating and testing patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to improve immunotherapy against malignant tumors.

Related Keywords

Indiana ,United States ,Purdue University ,Yoon Yeo ,Laura Thomson ,Joe Kasper ,Lillian Barboul Thomas ,Trademark Office ,Cancer Immunotherapy Systemic Delivery Purdue University ,Purdue Institute For Drug Discovery ,Purdue Innovates Office Of Technology Commercialization ,College Of Pharmacy ,National Institutes Of Health ,Translational Sciences Institute ,Translational Sciences ,National Center ,Department Head ,Purdue Institute For Cancer Research ,Bindley Bioscience Center ,Metabolite Profiling Facility ,Purdue Institute ,Cancer Research ,Lillian Barboul Thomas Professor ,Molecular Pharmaceutics ,Biomedical Engineering ,Drug Discovery ,Associate Department Head ,National Institutes ,Purdue Innovates Office ,Technology Commercialization ,Indiana Clinical ,Advancing Translational Sciences ,